Exact Mass: 342.25184440000004

Exact Mass Matches: 342.25184440000004

Found 46 metabolites which its exact mass value is equals to given mass value 342.25184440000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Myristoyl Asparagine

3-carbamoyl-2-tetradecanamidopropanoic acid

C18H34N2O4 (342.25184440000004)


N-myristoyl asparagine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Myristic acid amide of Asparagine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Myristoyl Asparagine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Myristoyl Asparagine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Cardenolide

3-(10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2H-furan-5-one

C23H34O2 (342.2558664)


   

1,1,1-Trifluorohenicosa-6,9,12,15-tetraene

1,1,1-Trifluorohenicosa-6,9,12,15-tetraene

C21H33F3 (342.25342140000004)


   

Retinyl propionate

3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl propanoic acid

C23H34O2 (342.2558664)


   

4-(10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)oxolan-2-one

4-(10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)oxolan-2-one

C23H34O2 (342.2558664)


   
   

Methyl docosahexaenoate; all cis-DHA methyl ester

Methyl docosahexaenoate; all cis-DHA methyl ester

C23H34O2 (342.2558664)


   

24-Nor-cholen-(4)-dion-(3.22)|24-nor-cholene-(4)-dione-(3.22)|24-norchol-4-ene-3,22-dione

24-Nor-cholen-(4)-dion-(3.22)|24-nor-cholene-(4)-dione-(3.22)|24-norchol-4-ene-3,22-dione

C23H34O2 (342.2558664)


   

10(Z),13(E),15(E)-heptadecatrienylhydroquinone

10(Z),13(E),15(E)-heptadecatrienylhydroquinone

C23H34O2 (342.2558664)


   

(6Z,8E)-6,8-Tricosadiene-4,19-diynoic acid

(6Z,8E)-6,8-Tricosadiene-4,19-diynoic acid

C23H34O2 (342.2558664)


   

3-(8,11,14-Heptadecatrienyl)-1,2-benzenediol

3-(8,11,14-Heptadecatrienyl)-1,2-benzenediol

C23H34O2 (342.2558664)


   

Retinyl Propionate-[d3]

Retinyl Propionate-[d3]

C23H34O2 (342.2558664)


   

4-methoxy-2-methyl-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]phenol|farnesylol

4-methoxy-2-methyl-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]phenol|farnesylol

C23H34O2 (342.2558664)


   
   
   

(10R)-3c-Acetoxy-10r.13c-dimethyl-17c-vinyl-(8cH.9tH.14tH)-Delta5-tetradecahydro-1H-cyclopenta[a]phenanthren|3-O-acetylpregna-5,20-dien-3beta-ol|3beta-acetoxy-pregnadiene-(5,20)|3beta-acetoxypregna-5,20-diene|Essigsaeure-(pregnadien-(5.20)-yl-(3beta)-ester)|pregna-5,20-dien-3beta-ol-3-acetate|pregna-5,20-dien-3beta-yl acetate

(10R)-3c-Acetoxy-10r.13c-dimethyl-17c-vinyl-(8cH.9tH.14tH)-Delta5-tetradecahydro-1H-cyclopenta[a]phenanthren|3-O-acetylpregna-5,20-dien-3beta-ol|3beta-acetoxy-pregnadiene-(5,20)|3beta-acetoxypregna-5,20-diene|Essigsaeure-(pregnadien-(5.20)-yl-(3beta)-ester)|pregna-5,20-dien-3beta-ol-3-acetate|pregna-5,20-dien-3beta-yl acetate

C23H34O2 (342.2558664)


   

Grifolin monomethyl ether

Grifolin monomethyl ether

C23H34O2 (342.2558664)


   

(8Z,11Z,14Z)-5-(heptadeca-8,11,14-trienyl)benzene-1,3-diol|5,6-Dihydro-(all-Z)-5-(5,8,11,14-Heptadecatetraenyl)-1,3-benzenediol|5-heptadecatri-8(Z),11(Z),14(Z)-enylresorcinol

(8Z,11Z,14Z)-5-(heptadeca-8,11,14-trienyl)benzene-1,3-diol|5,6-Dihydro-(all-Z)-5-(5,8,11,14-Heptadecatetraenyl)-1,3-benzenediol|5-heptadecatri-8(Z),11(Z),14(Z)-enylresorcinol

C23H34O2 (342.2558664)


   
   

Cannabidiol dimethyl ether

Cannabidiol dimethyl ether

C23H34O2 (342.2558664)


   

Docosahexaenoic Acid methyl ester

4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid, methyl ester

C23H34O2 (342.2558664)


   

TrHA

5Z,8Z,11Z,14Z,17Z,20Z-tricosahexaenoic acid

C23H34O2 (342.2558664)


   

FA 23:6

5Z,8Z,11Z,14Z,17Z,20Z-tricosahexaenoic acid

C23H34O2 (342.2558664)


   

5-((8Z,11Z,14Z)-heptadeca-8,11,14-trien-1-yl)resorcinol

5-((8Z,11Z,14Z)-heptadeca-8,11,14-trien-1-yl)benzene-1,3-diol

C23H34O2 (342.2558664)


   

5-((5Z,8Z,11Z)-heptadeca-5,8,11-trien-1-yl)resorcinol

5-((5Z,8Z,11Z)-heptadeca-5,8,11-trien-1-yl)benzene-1,3-diol

C23H34O2 (342.2558664)


   

5-((8Z,11Z,14E)-heptadeca-8,11,14-trienyl) resorcinol

5-((8Z,11Z,14E)-heptadeca-8,11,14-trienyl) resorcinol

C23H34O2 (342.2558664)


   

4,7,10,13,16,19-Docosahexaenoic acid, methyl ester

cis-4,7,10,13,16,19-docosahexaenoic acid methyl ester

C23H34O2 (342.2558664)


   

methyl docosahexaenoate

methyl docosahexaenoate

C23H34O2 (342.2558664)


   

Retinyl Propionate

Retinyl Propionate

C23H34O2 (342.2558664)


D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

   

2-Mercaptoethyl oleate

2-Mercaptoethyl oleate

C20H38O2S (342.2592368)


   

Cardenolide

Cardenolide

C23H34O2 (342.2558664)


D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

   

1,3-Benzenediol, 5-(8,11,14-heptadecatrienyl)-, (Z,Z,Z)-

1,3-Benzenediol, 5-(8,11,14-heptadecatrienyl)-, (Z,Z,Z)-

C23H34O2 (342.2558664)


   
   

1,1,1-Trifluorohenicosa-6,9,12,15-tetraene

1,1,1-Trifluorohenicosa-6,9,12,15-tetraene

C21H33F3 (342.25342140000004)


   

L-Leucine, N-(N-acetyl-L-leucyl)-, butyl ester

L-Leucine, N-(N-acetyl-L-leucyl)-, butyl ester

C18H34N2O4 (342.25184440000004)


   

5Z,8Z,11Z,14Z,17Z,20Z-tricosahexaenoic acid

5Z,8Z,11Z,14Z,17Z,20Z-tricosahexaenoic acid

C23H34O2 (342.2558664)


   

6Z,8E-tricosdien-4,19-diynoic acid

6Z,8E-tricosdien-4,19-diynoic acid

C23H34O2 (342.2558664)


   

Tricosahexaenoic acid

Tricosahexaenoic acid

C23H34O2 (342.2558664)


   
   

5-(heptadeca-8,11,16-trien-1-yl)benzene-1,3-diol

5-(heptadeca-8,11,16-trien-1-yl)benzene-1,3-diol

C23H34O2 (342.2558664)


   

5-[(8z,11z,14z)-heptadeca-8,11,14-trien-1-yl]benzene-1,3-diol

5-[(8z,11z,14z)-heptadeca-8,11,14-trien-1-yl]benzene-1,3-diol

C23H34O2 (342.2558664)


   

(2e,4z,6z)-7-[2-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)ethyl]-8h-oxocin-3-ol

(2e,4z,6z)-7-[2-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)ethyl]-8h-oxocin-3-ol

C23H34O2 (342.2558664)


   

4-methoxy-5-methyl-2-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]phenol

4-methoxy-5-methyl-2-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]phenol

C23H34O2 (342.2558664)